• 1. Five novel Zn(ii)/Cd(ii) coordination polymers based on bis(pyrazinyl)-triazole and varied polycarboxylates: syntheses, topologies and photoluminescence
  Jie Pan,Fei-Long Jiang,Ming-Yan Wu,Lian Chen,Jin-Jie Qian,Kong-Zhao Su,Xiu-Yan Wan,Mao-Chun Hong CrystEngComm 2014 16 11078
• 2. An iron-based metal–organic framework for selective CO2 adsorption and as an efficient anode material for lithium-ion batteries
  Y B. N. Tran,Phuong T. K. Nguyen,Tuan Loi Nguyen New J. Chem. 2023 47 10687
• 3. Synthesis, characterization, and magnetic studies of a series of metal–mellitate coordination polymers
  Meng-Yuan Li,Slavi C. Sevov CrystEngComm 2013 15 1225
• 4. The chemistry and applications of hafnium and cerium(iv) metal–organic frameworks
  Zhigang Hu,Yuxiang Wang,Dan Zhao Chem. Soc. Rev. 2021 50 4629
• 5. Determination of impurity elements in graphite by acid decomposition–inductively coupled plasma atomic emission spectrometry
  Kazuo Watanabe,Jun Inagawa Analyst 1996 121 623

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Hexacarboxylic acids and derivatives
• Other Chemical Reagents

Recent Advances in Mellitic Acid (517-60-2) Research: Applications and Innovations in Chemical Biomedicine

Mellitic acid (CAS: 517-60-2), also known as benzenehexacarboxylic acid, has garnered significant attention in the field of chemical biomedicine due to its unique structural properties and versatile applications. Recent studies have explored its potential in drug delivery systems, biomaterials, and diagnostic tools, highlighting its role as a multifunctional compound. This research briefing synthesizes the latest findings on mellitic acid, focusing on its chemical properties, biomedical applications, and emerging trends in research.

One of the most notable advancements in mellitic acid research is its application in the development of novel drug delivery systems. Researchers have leveraged its high solubility and stability to design nanocarriers capable of targeted drug release. A 2023 study published in the Journal of Controlled Release demonstrated that mellitic acid-based nanoparticles exhibited enhanced biocompatibility and controlled release kinetics for anticancer agents, offering a promising alternative to conventional delivery methods. The study also highlighted the compound's ability to form stable complexes with metal ions, which could be exploited for theranostic applications.

In addition to drug delivery, mellitic acid has shown potential in the fabrication of advanced biomaterials. A recent investigation in Biomaterials Science revealed that mellitic acid-derived polymers exhibited exceptional mechanical strength and biodegradability, making them suitable for tissue engineering scaffolds. The study emphasized the compound's ability to crosslink with natural polymers like collagen, thereby enhancing the structural integrity of hybrid materials. These findings underscore mellitic acid's versatility in addressing challenges in regenerative medicine.

Another groundbreaking area of research involves the use of mellitic acid in diagnostic imaging. A 2024 study in Analytical Chemistry reported the development of mellitic acid-based contrast agents for magnetic resonance imaging (MRI). The researchers found that the compound's six carboxyl groups allowed for efficient chelation of gadolinium ions, resulting in high-contrast imaging with minimal toxicity. This innovation could pave the way for safer and more effective diagnostic tools in clinical settings.

Despite these promising developments, challenges remain in the large-scale synthesis and commercialization of mellitic acid-based products. Recent reviews in Chemical Reviews have pointed out the need for more sustainable production methods and rigorous toxicity assessments. However, the growing body of research suggests that mellitic acid holds immense potential for transformative applications in chemical biomedicine. Future studies are expected to focus on optimizing its properties and expanding its utility in personalized medicine and smart therapeutics.

• 28965-86-8(Benzoic acid, hydroxymethyl-)
• 25610-19-9(POLYETHYLENEPHTHALATE)
• 18190-63-1(1,3-Benzenedicarboxylic acid, 2,4-dimethyl-)
• 70838-83-4(Phthalic-13C Acid)
• 29932-94-3(Benzenedicarboxylic acid, methyl-)
• 503470-23-3(4-formyl-2-methylbenzoic acid)
• 207742-73-2(o-toluic-d7 acid)
• 8023-83-4(2,6-Dimethylterephthalic acid)
• 27458-15-7(Benzoic acid, trimethyl-)
• 2790-09-2(4,6-Dimethylisophthalic acid)